Abstract
Charcot-Marie-Tooth (CMT) disease is a typical example of a clinically and genetically heterogeneous disorder and, in most cases, is dominantly inherited and caused by a 1.5 megabase duplication on chromosome 17p11.2 containing the PMP22 gene. This is a non-lethal disease with a wide spectrum of severity, from asymptomatism to severe motor and sensory disability. Unpredictable degree of disability is usually the reason why prenatal diagnosis is required and must be addressed. Molecular procedures such as the use of polymorphic non microsatellite STRs, allowing very fast and reliable results even when requiring a gene dosage interpretation are now available and have been recently validated in post-natal diagnosis. Our results indicate that this approach is also the best-adapted method in case of prenatal diagnosis. Nevertheless, ethical considerations raised by prenatal diagnosis in CMT and more generally in non-lethal disorders remain to be actively considered. Here, we present our experience in genetic counselling, and address the psychological issues for 7 CMT at risk pregnancies. In five cases, a CMT1A duplication was evidenced; pregnancy was terminated in four of these cases and the parents from one affected foetus decided to pursue the pregnancy.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Meuleman J, Timmerman V, Nelis E, De Jonghe P . Molecular genetics of inherited peripheral neuropathies: who are the actors? Acta Neurol Belg 2000 100: 171–180
Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A Cell 1991 66: 219–232
Lupski JR . Charcot-Marie-Tooth polyneuropathy: Duplication, Gene dosage, and Genetic Heterogeneity Pediatric Research 1999 45: 159–165
Valentijn LJ, Bolhuis RA, Zorn I et al. The peripheral myelin genePMP22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A Nature Genet 1992 1: 166–170
Reiter LT, Murakami T, Koeuth T et al. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element Nature Genet 1996 12: 288–297
Cudrey C, Chevillard C, Le Paslier D, Vignal A, Passage E, Fontes M . Assignment of microsatellite sequences to the region duplicated in CMT1A (17p12): a useful tool for diagnosis J Med Genet 1995 32: 231–233
Blair IP, Kennerson ML, Nicholson GA . Detection of Charcot-Marie-Tooth type 1A duplication by the polymerase chain reaction Clin Chem 1995 41: 1105–1108
Lopes J, LeGuern E, Gouider R et al. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditery neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A Am J Hum Genet 1996 58: 1223–1230
Yamamoto M, Yasuda T, Hayasaka K et al. Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP Hum Genet 1997 99: 151–154
Stronach EA, Clarck C, Bell C et al. Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and Hereditary neuropathy with liability to pressure palsies J Periph Nerv Syst 1999 4: 117–122
Bernard R, Labelle V, Negre P et al. Prenatal detection of a 17p11.2 duplication resulting from a rare recombination event and novel PCR-based strategy for molecular identification of Charcot-Marie-Tooth disease type 1A Eur J Hum Genet 2000 8: 229–235
Lebo RV, Martelli L, Su Y et al. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A by multicolor in situ hybridization Am J Med Genet 1993 47: 441–450
Navon R, Timmerman V, Lofgren A et al. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques Prenat Diagn 1995 15: 633–640
Kashork CD, Lupski JR, Shaffer LG . Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A by interphase fluorescence in situ hybridization Prenat Diagn 1999 19: 446–449
Latour P, Boutrand L, Lévy N et al. Polymorphic short tandem repeats for diagnosis of the Charcot-Marie-Tooth 1A duplication Clin Chem 2001 47: 829–837
Badano JL, Inoue K, Katsanis N, Lupski JR . New polymorphic short tandem repeats for PCR-based Charcot-Marie-Tooth disease type 1A duplication diagnosis Clin Chem 2001 47: 838–843
Ionasescu V . Charcot-Marie-Tooth neuropathies: from clinical descriptions to molecular genetics Muscle and Nerve 1995 18: 267–275
Birouk N, Gouider R, Le Guern E et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases Brain 1997 120: 813–823
Garcia CA . A clinical review of Charcot-Marie-Tooth Ann NY Acad Sci 1999 833: 69–76
Maniatis T . Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory Press 1989
Bui TH, Iselius L, Lindsten J . European collaborative study on prenatal diagnosis: mosaicism, pseudomosaicism and single abnormal cells in amniotic fluid cell cultures Prenat Diagn 1984 1: 145–162
Dematteis M, Pepin JL, Jeanmart M, Deschaux C, Labarre-Vila A, Levy P . Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study Lancet 2001 357: 267–272
impson SA, Harper PS . Prenatal testing for Huntington's disease: experience within the UK 1994-1998 J Med Genet 2001 38: 333–335
Tolmie JL, Davidson HR, May HM, McIntosh K, Paterson JS, Smith B . The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993 J Med Genet 1995 32: 97–101
Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Niermeijer MF . Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands J Med Genet 2000 37: 883–884
Levy M, Richard S . Attitudes of von Hippel-Lindau disease patients towards presymptomatic genetic diagnosis in children and prenatal diagnosis J Med Genet 2000 37: 476–478
De Vos A, Sermon K, Van de Velde H et al. Pregnancy after preimplantation genetic diagnosis for Charcot-Marie- Tooth disease type 1A Mol Hum Reprod 1998 4: 978–984
Acknowledgements
We are grateful to the patients, families and the CMT-France association who made this work possible, Michel Sokolowski for psychiatric evaluation of the requesting couples, Claude Desnuelle, Jean-Claude Lambert, Jean Pouget, Brigitte Chabrol for helpful collaboration. Amandine Boyer was supported by a grant from the Lion's club Marseille doyen. This work was supported by the Assistance Publique–Hôpitaux de Marseille.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bernard, R., Boyer, A., Nègre, P. et al. Prenatal detection of the 17p11.2 duplication in Charcot-Marie-Tooth disease type 1A: necessity of a multidisciplinary approach for heterogeneous disorders. Eur J Hum Genet 10, 297–302 (2002). https://doi.org/10.1038/sj.ejhg.5200804
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.ejhg.5200804
Keywords
This article is cited by
-
Provision and quality assurance of preimplantation genetic diagnosis in Europe
European Journal of Human Genetics (2008)
